Hologic, Inc. (LON:0J5Q)

Hologic Statistics

Total Valuation

Hologic has a market cap or net worth of GBP 12.47 billion. The enterprise value is 12.79 billion.

Market Cap	12.47B
Enterprise Value	12.79B

Important Dates

The next estimated earnings date is Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	222.91M
Shares Outstanding	n/a
Shares Change (YoY)	-4.20%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	0.92%
Owned by Institutions (%)	99.00%
Float	220.67M

Valuation Ratios

The trailing PE ratio is 29.56 and the forward PE ratio is 16.37.

PE Ratio	29.56
Forward PE	16.37
PS Ratio	4.08
PB Ratio	3.31
P/TBV Ratio	20.44
P/FCF Ratio	18.18
P/OCF Ratio	15.82
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.45, with an EV/FCF ratio of 18.63.

EV / Earnings	30.31
EV / Sales	4.18
EV / EBITDA	12.45
EV / EBIT	16.28
EV / FCF	18.63

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.52.

Current Ratio	3.75
Quick Ratio	2.87
Debt / Equity	0.52
Debt / EBITDA	1.90
Debt / FCF	2.85
Interest Coverage	9.06

Financial Efficiency

Return on equity (ROE) is 11.12% and return on invested capital (ROIC) is 8.58%.

Return on Equity (ROE)	11.12%
Return on Assets (ROA)	7.30%
Return on Invested Capital (ROIC)	8.58%
Return on Capital Employed (ROCE)	13.20%
Revenue Per Employee	432,490
Profits Per Employee	59,666
Employee Count	7,070
Asset Turnover	0.45
Inventory Turnover	2.36

Taxes

In the past 12 months, Hologic has paid 86.13 million in taxes.

Income Tax	86.13M
Effective Tax Rate	16.96%

Stock Price Statistics

The stock price has increased by +1.87% in the last 52 weeks. The beta is 0.70, so Hologic's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+1.87%
50-Day Moving Average	73.30
200-Day Moving Average	65.67
Relative Strength Index (RSI)	65.82
Average Volume (20 Days)	943

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.26

Income Statement

In the last 12 months, Hologic had revenue of GBP 3.06 billion and earned 421.84 million in profits. Earnings per share was 1.86.

Revenue	3.06B
Gross Profit	1.86B
Operating Income	791.25M
Pretax Income	507.96M
Net Income	421.84M
EBITDA	1.01B
EBIT	791.25M
Earnings Per Share (EPS)	1.86

Balance Sheet

The company has 1.64 billion in cash and 1.96 billion in debt, giving a net cash position of -313.86 million.

Cash & Cash Equivalents	1.64B
Total Debt	1.96B
Net Cash	-313.86M
Net Cash Per Share	n/a
Equity (Book Value)	3.76B
Book Value Per Share	16.91
Working Capital	2.01B

Cash Flow

In the last 12 months, operating cash flow was 788.27 million and capital expenditures -102.16 million, giving a free cash flow of 686.11 million.

Operating Cash Flow	788.27M
Capital Expenditures	-102.16M
Free Cash Flow	686.11M
FCF Per Share	n/a

Margins

Gross margin is 60.82%, with operating and profit margins of 25.88% and 13.80%.

Gross Margin	60.82%
Operating Margin	25.88%
Pretax Margin	16.61%
Profit Margin	13.80%
EBITDA Margin	32.95%
EBIT Margin	25.88%
FCF Margin	22.44%

Dividends & Yields

Hologic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.20%
Shareholder Yield	4.20%
Earnings Yield	3.38%
FCF Yield	5.50%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hologic has an Altman Z-Score of 4.05 and a Piotroski F-Score of 7.

Altman Z-Score	4.05
Piotroski F-Score	7